Guangdong Lingnan Pharmaceutical

Guangdong Lingnan Pharmaceutical is a high-tech pharmaceutical enterprise established in 1991 and headquartered in Shaoguan, Guangdong Province, China. The company specializes in the research, development, manufacturing, and commercialization of anti-tumor therapies and digestive system medications. Its comprehensive product portfolio features active pharmaceutical ingredients (APIs), solid oral dosages, and sterile injectables, including key products such as cisplatin, carboplatin, fluorouracil, methotrexate, and bismuth aluminate. Guangdong Lingnan Pharmaceutical operates two advanced production bases that integrate raw material synthesis with finished drug manufacturing. The company is recognized as a national high-tech enterprise and a provincial specialized and innovative enterprise within China's pharmaceutical sector.